Myocardial Dysfunction Evaluation in Lower Extremity Arterial Disease Patients With Deformation Analysis

Recruiting Observational Study
Peripheral Artery Disease Heart Failure
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
35 – 85
Sex
Any
Study type
Observational
Participants needed
162 (estimated)
Sponsor
Tartu University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Single centre observational study to assess lower extremity arterial disease (LEAD) patients' cardiac dysfunction with strain analyses and to assess connections between cardiac dysfunction, metabolomic changes and target organ damage in LEAD.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria in LEAD group: * Fontaine I-IV class symptoms * Confirmed diagnosis of LEAD Inclusion Criteria in control group: * Age 35-85 * Has to have at least of the following: hypertension, diabetes, coronary artery disease or the patient smokes Exclusion Criteria: * Age \<35 or \>85 y…
Contacts

Jaak Kals, PhD

731 8292

jaak.kals@ut.ee

CONTACT